16th International Primary Care Diabetes Europe Conference

This conference will take place on Thursday 15, Friday 16 and Saturday 17 June 2023, in the Barcelo Sants Hotel in Barcelona.
The conference had to be postponed due to pandemic travel restrictions, but now we are looking forward to meeting you again in person for this traditional PCDE CME event.

Become a PCDE member

If you are not a registered member yet, please register here to become a member. After approval you will be granted access to the online Journal of PCDE.


Welcome to PCDE

“Primary Care Diabetes Europe (PCDE) welcomes all healthcare professionals working for people with diabetes in a community setting.

PCDE offers:
an organisation representing your interests in major European organisations at political and professional levels, with the aim of highlighting the importance of the development of high quality diabetes services in all countries.

a recognised Academic Journal publishing original research – “Primary Care Diabetes”

PCDE is involved with and encourages research concerning Diabetes and all different aspects of its management in Primary Care.

PCDE organises a pan-European conference highlighting developments and challenges in Primary Care Diabetes management, the latest one was in April 2016.

PCDE forms an important link between Primary Care Diabetes societies where they exist across Europe, encouraging collaboration and the sharing of good practice.

The most important goal of PCDE is to support ‘best practice’ in diabetes care across Europe, for the benefit of all people with diabetes.


Primary Care Diabetes is the official journal of Primary Care Diabetes Europe (PCDE).

The journal publishes original research articles and high-quality reviews in the fields of clinical care, diabetes education, nutrition, health services, psychosocial research and epidemiology as far as is relevant for diabetology in a primary-care setting.

Not a subscriber yet?


PCDE TALKS The role of SGLT2 inhibitors in cardiorenal protection: state of the art.

The aim of this webinar is to revisit latest evidence on secondary preventive effect of SGLT2 inhibitor drugs.

The key learning objectives will be;

  1. To discuss the cardioprotective effects of SGLT2 inhibitors in terms of heart failure.
  2. To discuss the effect of SGLT2 inhibitors on kidney function

PCDE Talks – Last sessions

PCDE educational initiatives for primary care providers on management of type 2 diabetes

ANNOUNCEMENT: PCDE Study Group in primary care research is expanding..

Within PCDE we have recently created a Research Committee and I am delighted to introduce to you the committee members Dr. Ana Cebrian from Spain and Dr. Stefan Jansson from Sweden who are both authorities in their countries. Together we will work on PCDE’s research...


Early identification of CKD through screening, followed by accurate diagnosis and staging to inform the best treatment, offers the potential to significantly reduce the morbidity and mortality of this burdensome disease and its complications....

SGLT2 Inhibitors in Primary Care Practice

Four round table discussions around SGLT2 Inhibitors featuring: Dr Sam Seidu, Dr Clare Hambling, Professor Ana Cebrián and Professor Baruch Itzhak. The topics covered in this online learning are: SGLT2 inhibitors in primary care practiceDiabetes, renal and...

ANNOUNCEMENT: 16th International PCDE Conference, 15-17 June 2023 – Barcelona

We are delighted to invite you to the 16th International Primary Care Diabetes Europe (PCDE) Conference which will be held in Barcelona again.The program and other details will be published shortly and registration will be opened soon.This conference, which we...